Please ensure Javascript is enabled for purposes of website accessibility cir no 16.Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) cir no 16.Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

cir no 16.Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Content Details
Pharmacovigilance Department News and Safety Alerts
cir no 16.Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
17/02/2026

cir no 16.Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

View Download
0
cir no 16.Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Was this page helpful?
0 visitors liked this page of total 0 visitors
Be the first to evaluate this page

Add Reason (choose at least one)

الرجاء اختيار سببان كحد أعلى

هذا الحقل مطلوب

الرجاء كتابة نص صحيح

الملاحظات يجب ان تكون اقل من ٢٥٠ حرف

Share this page
Follow Us On